Smoking and the molecular epidemiology of lung cancer

Clinics in Chest Medicine

Volumn 21, Issue 1, 2000, Pages 87-93

  Christiani, David C ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BENZO[A]PYRENE; CIGARETTE SMOKE; HEAVY METAL; PETROLEUM; RADIOACTIVE MATERIAL;

CANCER RISK; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; INHALATION; LUNG CANCER; LUNG CARCINOGENESIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

EID: 0034115572     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70009-5     Document Type: Article

References (59)

1. I. Adler Primary malignant growths of the lung and bronchi 1912 Longmans Green & Co London
2. D.J. Benford J.W. Bridges Xenobiotic metabolism in lung J.W. Bridges L.F. Chasseaud Progress in Drug Metabolism 1986 Taylor and Francis London 53 94
3. V.A. Bohr D.H. Phillips P.C. Hanawalt Heterogeneous DNA damage and repair in the mammalian genome Cancer Res 47 1987 6426 6436
4. B. Burrough J. Helyar Barbarians at the Gate: The Fall of RJR Nabisco 1990 Harper and Row New York
5. D.C. Christiani Utilization of biomarker data for clinical and environmental intervention Environ Health Perspect 104 Suppl 5 1996 921 925
6. D.C. Christiani Occupational lung cancer D.E. Banks J.E. Parker Occupational Lung Diseases 1998 Chapman and Hall London
7. S.C. Darby J.M. Samet Radon J.M. Samet Epidemiology of Lung Cancer 1994 Marcel Dekker New York
8. R. Doll A.B. Hill Smoking and carcinoma of the lung Br Med J 2 1950 739
9. N. Drakoulis I. Cascorbi I. Brockmoller Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: Exon 7 mutation (4889 A to G) and a T to C mutation in the 3′-flanking region Clin Invest 72 1994 240 248
10. N.A. Ellis J. Groden T.Z. Ye The Bloom's syndrome gene product is homologous to RecQ helicases Cell 83 1995 566 666
11. M. Garcia-Closas K.T. Kelsey J.K. Wiencke Glutathione S-transferase class μ polymorphism and lung cancer susceptibility; interactions with CYP1A1 Msp1 polymorphism and cigarette dose Cancer Causes Control 8 1997 544 553
12. R.A. Gatti Ataxia-telangiectasia Dermatol Clin 13 1995 1 6
13. J. German Bloom's syndrome Dermatol Clin 13 1995 7 18
14. Gonzalez FJ, Crespi CL, Gelboin HV. CDNA-Expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment. Mutation Res 247:113–127.
15. P.C. Hanawalt Transcription-coupled repair and human disease Science 266 1994 1957 1958
16. E. Harlow An introduction to the puzzle Cold Spring Harb Symp Quant Biol LIX 1994 709 723
17. S. Hayashi J. Watanabe K. Nakachi Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene J Biochem 110 1991 407 411
18. A. Hirvonen K. Husgafvel-Pursiainen A. Karjalainen Point-mutational MspI and Ile-VaI polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population Cancer Epidemiol Biomarkers Prev 1 1992 485 489
19. A. Hirvonen K. Husgafvel-Puriainen S. Anttila The human CYP2E1 gene and lung cancer: Dra1 and Rsa1 restriction fragment length polymorphisms in a Finnish study population Carcinogenesis 14 1993 85 88
20. D. Hoffmann S.S. Hecht Nicotine-derived N-nitrosamines and tobacco-related cancer: Current status and future directions Cancer Res 45 1985 935 944
21. N. Ishibe J.K. Wiencke Z.-F. Zuo Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans Cancer Epidemiol Biomarkers Prev 6 1997 1075 1080
22. F. Kadlubar G.J. Hammons Role of cytochrome P-450 in metabolism of chemical carcinogens F.P. Guengerich Mammalian Cytochromes P-450 vol. 2 1987 CRC Press Boca Raton, FL 81 130
23. S. Kato P.G. Shields N.E. Caporaso Analysis of cytochrome P4502E1 genetic polymorphisms in relation to human lung cancer Cancer Epidemiol Biomarkers Prev 3 1994 515 518
24. K. Kawajiri K. Nakachi K. Imai Identification of genetically high-risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene FEBS Lett 263 1990 131 133
25. A.G. Knudson Jr Mutation and cancer: Statistical study of retinoblastoma Proc Natl Acad Sci USA 68 1971 820 823
26. W.C. Lambert H.R. Kuo M.W. Lambert Xeroderma pigmentosum Dermatol Clin 13 1995 169 209
27. M.R. Law Genetic predisposition to lung cancer Br J Cancer 61 1990 195
28. G.L. Law R.T. Falk L.W. Pickle Lung cancer risk associated with cancer in relatives J Clin Epidemiol 44 1991 429 437
29. W. Marshall K.H. Vousden D.H. Phillips Activation of c-Ha- ras -1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide Nature 310 1984 586 589
30. C.W. Miller K. Simon A. Aslo Mutations in human lung tumors Cancer Res 52 1992 1695 1698
31. F.H. Muller Tabakmissbrauch und lungencarcinom 2 Z Krebsforsch 49 1939 57 85
32. F. Oesch W. Aulmann K.L. Platt Individual differences in DNA repair capacities in man Arch Toxicol 10 suppl 1987 172 179
33. T. Okada K. Kawashima S. Fukushi Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer Pharmacogenetics 4 1994 333 340
34. W.L. Ooi R.C. Elston V.W. Chen Increased familial risk for non-lung cancer among relatives of lung cancer patients J Natl Cancer Inst 76 1986 217 222
35. I. Persson I. Johansson H. Bergling Genetic polymorphism of cytochrome P4502E1 in a Swedish population: Relationship to incidence of lung cancer FEBS Lett 319 1993 207 211
36. A.H. Roffo Der Tabak als krebserzeugende agens Dtsch Med Wochnschr 63 1937 1267 1271
37. A.H. Roffo Krebseizeugendes Benzpyren gewonnen aus Tabakteer Z Krebsforsch 49 1937 588 597
38. H. Rottman Uber primare Lungencarcinoma. Inaugural dissertation 1898 Universitat Wurzburg
39. K. Savitsky A. Barshira S. Gilad A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
40. E. Schairer E. Schoniger Lungenkrebs und tabakverbrauch Z Krebsforsch 54 1943 261 269
41. I.J. Selikoff E.C. Hammond H. Seidman Mortality experience of insulation workers in the United States and Canada, 1943–1976 Ann NY Acad Sci 330 1979 91 116
42. T.A. Sellers W.L. Ooi R.C. Elston Increased familial risk for non-lung cancer among relatives of lung cancer patients Am J Epidemiol 126 1987 237 246
43. T.A. Sellers R.C. Elston C. Stewart Familial risk of cancer among randomly selected cancer probands Genet Epidemiol 5 1987 381 392
44. T.A. Sellers J.E. Bailer-Wilson R.C. Elston Evidence for Mendelian inheritance in the pathogenesis of lung cancer J Natl Cancer Inst 1990
45. P.G. Shields N.E. Caporaso R.T. Falk Lung cancer, race and a CYP1A1 genetic polymorphism Cancer Epidemiol Biomark Prev 2 1993 481 485
46. 1450) gene: Lack of association between the Msp1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population Pharmacogenetics 1 1991 20 25
47. G.K. Tokuhata A.M. Lillienfeld Familial aggregation of lung cancer in humans J Natl Cancer Inst 30 1963 289 312
48. F. Uematsu H. Kikuchi M. Motomiya Association between restriction fragment length polymorphism of the human cytochrome P45011E1 gene and susceptibility to lung cancer Jpn J Cancer Res 82 1991 254 256
49. US Department of Health and Human Services The health consequences of smoking: 25 years of progress 1989 US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Office of Smoking and Health Washington, DC DHHS Publication No. (CDC) 89-8411
50. US Department of Health and Human Services Smoking and Health in the Americas 1992 US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Office on Smoking and Health Washington, DC DHHS Publication No. (CDC) 92-8419
51. P. Vineis H. Bartsch N. Caporaso Genetically-based N -acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature 369 1994 154 156
52. K.H. Vousden J.L. Bos C.J. Marshall Mutations activating human c-Ha ras proto-oncogene (HRAS1) induced by chemical carcinogens and depurination Proc Natl Acad Sci USA 83 1986 1222 1226
53. J. Watanabe J.-P. Yang H. Eguchi A Rsa1 polymorphism in the CYP1E1 gene does not affect lung cancer risk in a Japanese population Jpn J Cancer Res 86 1995 245 248
54. J. Wiencke A. Varkonyi K. Semey Validation of blood mononuclear cell DNA-adducts as a marker of DNA damage in human lung Cancer Research 55 1995 4910 4915
55. G.N. Wogan N.S. Gorelick An overview of chemical and biochemical dosimetry of exposure to genotoxic chemicals Environ Health Perspect 62 1985 5 18
56. X. Wu H. Shi H. Jiang Associations between cytochrome P4502E1 genotype, mutation sensitivity, cigarette smoking and susceptibility to lung cancer Carcinogenesis 18 1997 967 973
57. X.F. Wu C.I. Amos B.L. Kemp Cytochrome P4502E1 Dra1 polymorphism in lung cancer in minority populations Cancer Epidemiol Biomark Prev 7 1998 13 18
58. E.L. Wynder E.A. Graham Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma JAMA 143 1950 329 336
59. X. Xu K.T. Kelsey J.K. Wiencke Cytochrome P450 CYP1A1 Msp1 polymorphism and lung cancer susceptibility Cancer Epidemiol Biomark Prev 5 1996 687 692